Physician profile
Joseph Bax
NPI 1750417283
$56,869.25
in general payments reported to CMS, 2019-2025
19 companies · $4,951 in 2025
The $4,951 reported for 2025 was more than what 94% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,165 · 2020: $1,777 · 2021: $8,270 · 2022: $9,044 · 2023: $25K · 2024: $4,790 · 2025: $4,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $7,668 · Travel and Lodging: $1,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,225.00 |
| Food and Beverage | $7,667.94 |
| Travel and Lodging | $1,720.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $27,628.40 | 2022-2024 | Evoke Scs, Evoke |
| Medtronic, INC. | $17,944.18 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Cd Horizon Spinal System |
| Medtronic USA, INC. | $4,686.18 | 2019-2020 | |
| Arcutis Biotherapeutics, INC. | $2,275.00 | 2025 | Zoryve |
| Boston Scientific Corporation | $1,207.52 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Relievant Medsystems, INC. | $915.23 | 2021-2023 | Intracept |
| Si-Bone, INC. | $578.34 | 2021-2022 | |
| Vertos Medical, INC. | $328.92 | 2024 | Mild Device Kit |
| Abbott Laboratories | $183.22 | 2022-2025 | Proclaim |
| Bioventus LLC | $182.05 | 2023 | Stimrouter Implantable Kit |
| Biotronik Nro, INC. | $173.43 | 2025 | Prospera |
| Alphatec Spine, INC | $166.94 | 2024 | Invictus Open |
| Nevro Corp. | $161.09 | 2019 | |
| Zimvie INC. | $140.26 | 2023 | |
| Atricure, INC. | $130.27 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $94.98 | 2019 | |
| Arthrex, INC. | $34.00 | 2025 | |
| Abbvie INC. | $33.85 | 2023 | Botox |
| Mml US, INC. | $5.39 | 2023 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.